secwatch / observer

8-K filed February 24, 2026, 6:59 PM ET ticker ONCY CIK 0001129928

other material confidence high sentiment positive materiality 0.75

Oncolytics prioritizes SCAC and CRC registration studies; GOBLET enrollment closed

ONCOLYTICS BIOTECH INC

Concluded enrollment in GOBLET gastrointestinal study; now focusing on registrational studies in squamous cell anal cancer (SCAC) and metastatic colorectal cancer (CRC).
Plans to meet with FDA mid-April to align on single-arm SCAC registrational study; believes <100 subjects may be sufficient for approval.
GOBLET Cohort 5 (PDAC) enrollment stopped at ~20 patients per arm; data to inform future PDAC strategy.
Sufficient cash on hand to execute near-term milestones, avoiding immediate material dilution.
GOBLET data support platform approach in GI cancers; company will follow existing Cohort 5 patients for survival data.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001129928-26-000006
form_type: 8-K
ticker: ONCY
cik: 0001129928
company_name: ONCOLYTICS BIOTECH INC
filed_at: 2026-02-24T23:59:59+00:00
discovered_at: 2026-05-14T18:02:34.594417+00:00
generated_at: 2026-05-16T00:39:34.720111+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001129928-26-000006
json_url: https://secwatch.observer/filing/0001129928-26-000006.json
markdown_url: https://secwatch.observer/filing/0001129928-26-000006.md
text_url: https://secwatch.observer/filing/0001129928-26-000006.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000006/0001129928-26-000006-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000006/oncy-20260224.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

QMCO

Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance

QUANTUM CORP /DE/ June 2, 2026, 10:41 AM ET other_material Items 1.01, 2.02, 2.03, 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CELC

Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial

Celcuity Inc. June 2, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FLGT

Fulgent Genetics reports encouraging Phase 2 data for FID-007 in HNSCC at ASCO 2026

Fulgent Genetics, Inc. June 1, 2026, 7:07 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

PECE

Peace Acquisition Corp closes IPO of 6M units at $10.00/unit, raising $60M

Peace Acquisition Corp. June 1, 2026, 5:16 PM ET other_material Items 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MVIS

MicroVision seeks reverse stock split approval; ratio 1:5 to 1:15; annual meeting July 10, 2026

MICROVISION, INC. June 1, 2026, 5:02 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

VDTA

Vertical Data launches Vertical Edge, a direct-ownership edge data center platform

Vertical Data Inc. June 1, 2026, 4:47 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

XAIR

Beyond Air receives Nasdaq panel grant for continued listing; must meet bid price rule by July 31, 2026

Beyond Air, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001129928-26-000006

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.